Search Results - "Mishell, D.R"

Serum ethinyl estradiol levels with a low-dose combination transdermal contraceptive (AG200-15) compared with a low-dose combination oral contraceptive by Archer, D.F, Stancyk, F.Z, Rubin, A, Flood, L.J, Mishell, D.R, Foegh, M

Get full text

Evaluation of exposure to ethinyl estradiol (EE) with a low dose combination transdermal contraceptive delivery system (AG200-15) compared to low-dose combination oral contraceptive by Archer, D.F, Stanczyk, F.Z, Rubin, A, Flood, L.J, Mishell, D.R, Foegh, M

Get full text

Follicular development during a 7- vs. 4-day hormone-free interval with an oral contraceptive containing 20 mcg of ethinyl estradiol and 1 mg norethindrone acetate by Rible, R, Taylor, D, Tilley, I, Segall-Gutierrez, P, Lewis, R, Mishell, D.R

Get full text

Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women by Fraser, I.S., Lähteenmäki, P., Elomaa, K., Lacarra, M., Mishell, D.R., Alvarez, F., Brache, V., Weisberg, E., Hickey, M., Vallentine, P., Nash, H.A.

“…A total of 107 sexually active women, aged 18–35 years, was recruited through family planning clinics in four centres in different countries. Each woman…”
Get full text

Levonorgestrel capsule implants in the United States: a 5-year study by Sivin, Irving, Mishell, D.R, Darney, Philip, Wan, Livia, Christ, Mercedes

“…Objective: To measure effectiveness, adverse event experience, and acceptability of the Food and Drug Administration–approved variant of levonorgestrel capsule…”
Get full text

Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS by Sivin, I, Stern, J, Coutinho, E, Mattos, C E, el Mahgoub, S, Diaz, S, Pavez, M, Alvarez, F, Brache, V, Thevenin, F

“…A levonorgestrel-releasing IUD and the Copper T 380Ag IUD were in randomized comparison for seven years in five clinics. In two other clinics the randomized…”
Get more information

Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study by Sivin, I, el Mahgoub, S, McCarthy, T, Mishell, Jr, D R, Shoupe, D, Alvarez, F, Brache, V, Jimenez, E, Diaz, J, Faundes, A

“…An intrauterine device, releasing approximately 20 micrograms/day of levonorgestrel (LNg 20), used by 1124 women, was studied in a randomized trial of five…”
Get more information

Overview — Meeting contraceptive needs worldwide: the role of monthly combined contraceptives by Kaunitz, A.M, Mishell, D.R

Get full text

Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring by Weisberg, E., Fraser, I.S., Lacarra, M., Mishell, D.R., Jackanicz, T.

“…The study population included 159 women aged 18 to 37 years requiring contraception (60 in Sydney; 99 in Los Angeles). The design consisted of a 6-month study…”
Get full text

Infertility. Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women by Fraser, I S, Lahteenmaki, P, Elomaa, K, Lacarra, M, D.R. Mishell, Jr, Alvarez, F, Brache, V, Weisberg, E, Hickey, M, Vallentine, P, Nash, H A

“…A total of 107 sexually active women, aged 18-35 years, was recruited through family planning clinics in four centres in different countries. Each woman…”
Get full text

Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas by March, C M, Kletzky, O A, Davajan, V, Teal, J, Weiss, M, Apuzzo, M L, Marrs, R P, Mishell, Jr, D R

“…A group of 43 patients with galactorrhea, hyperprolactinemia, and radiographic evidence of pituitary adenomas were followed from 3 to 20 years. Initial…”
Get more information

Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device by Belhadj, H, Sivin, I, Diaz, S, Pavez, M, Tejada, A S, Brache, V, Alvarez, F, Shoupe, D, Breaux, H, Mishell, Jr, D R

“…Following use of either the Levonorgestrel 20 mcg/day or the TCu 380 Ag IUD in a randomized comparative study, 110 women stopped contracepting to have planned…”
Get more information

Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose by Mishell, Jr, D R, Shoupe, D, Brenner, P F, Lacarra, M, Horenstein, J, Lahteenmaki, P, Spitz, I M

“…RU 486 is a synthetic steroid which has antiprogesterone and antiglucocorticoid activity. In order to determine the optimal dosage of this drug to terminate…”
Get more information

Pregnancy termination with a high and medium dosage regimen of RU 486 by Shoupe, D, Mishell, Jr, D R, Brenner, P F, Spitz, I M

“…Sixty healthy pregnant women who wished to terminate their pregnancy and who were no more than 49 days pregnant were treated with one of three different dose…”
Get more information

Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration by Stanczyk, F Z, Hiroi, M, Goebelsmann, U, Brenner, P F, Lumkin, M E, Mishell, Jr, D R

Get more information

Male pseudohermaphroditism consistent with 17,20-desmolase deficiency by Goebelsmann, U, Zachmann, M, Davajan, V, Israel, R, Mestman, J H, Mishell, D R

“…A 16-year-old phenotypic female with XY genotype presented an unusual form of nonfamilial male pseudohermaphroditism. Seemingly a normal girl during childhood,…”
Get more information

Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration by Hiroi, M, Stanczyk, F Z, Goebelsmann, U, Brenner, P F, Lumkin, M E, Mishell, Jr, D R

“…A radioimmunoassay (RIA) method for measuring medroxyprogesterone acetate (MPA, Provera) in serum has been developed utilizing benzene:iso-octane extraction,…”
Get more information

A method of solid phase radioimmunoassay utilizing polypropylene discs by Crosignani, P G, Nakamura, R M, Hovland, D N, Mishell, Jr, D R

Get more information

Experience with the copper-T and Silicone Shell Loop in parous women: a randomized study by Roy, S, Azen, S P, Mishell, Jr, D R, Pike, M C, Casagrande, J

Get more information

Immunoassay of HPL by complement fixation by Nakamura, R M, Theppisai, H, Okada, D M, Mishell, Jr, D R

Get more information